Community Diagnostic Service within Cheshire East and Cheshire West

Location

Patient registered with a Cheshire East Place or Cheshire West Place GP

Description

The service provides a community ultrasound service for Cheshire East and Cheshire West registered patients with the aim of aiding early diagnostics and avoid the need for unnecessary referral to secondary care clinicians for conditions that can be appropriately management within a Primary Care setting.

Total Quantity or Scope

NHS Cheshire and Merseyside ICB - Cheshire East intend to award a 1 year contract via Direct Award C to incumbent provider to deliver the Community Diagnostic Service in Cheshire East and Cheshire West. The contract will commence on the 14th May 2025 and expire on the 31st March 2026 and has a contract value of £287,262

Award Detail

Award Criteria

CPV Codes

• 85100000 - Health services

Legal Justification

This is a Provider Selection Regime (PSR) confirmation of contract award notice. This contract has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award

Other Information

** PREVIEW NOTICE, please check Find a Tender for full details. ** This is a Provider Selection Regime (PSR) confirmation of contract award notice. This contract has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. On the 19th of November 2024 the Finance, Investment, Resources Committee approved this decision. One committee member has a standing declaration of interest. The decision to award was made in line with the Conflict of Interest policy. Representations by providers must be made to sally.williams@cheshireandmerseyside.nhs.uk within 8 working days from the publication date of this notice. This contract has not yet formally been awarded; this notice serves as an intention to award under the Provider Selection Regime (2023).